Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 72.22%3.17B | 49.66%1.39B | 76.55%4.55B | 51.57%2.94B | 50.06%1.84B | 57.33%931.7M | -38.77%2.58B | -46.79%1.94B | -55.15%1.23B | --592.2M |
| Operating income | 72.22%3.17B | 76.55%4.55B | 50.06%1.84B | -38.77%2.58B | -55.15%1.23B | |||||
| Cost of sales | -72.31%-3.05B | ---- | -81.17%-4.35B | ---- | -55.37%-1.77B | ---- | 37.83%-2.4B | ---- | 54.87%-1.14B | ---- |
| Operating expenses | -72.31%-3.05B | -81.17%-4.35B | -55.37%-1.77B | 37.83%-2.4B | 54.87%-1.14B | |||||
| Gross profit | 70.03%118.35M | 12.79%196.32M | -19.79%69.61M | -49.37%174.05M | -58.46%86.77M | |||||
| Selling expenses | -20.76%-7.02M | ---- | 60.44%-7.84M | ---- | 52.58%-5.81M | ---- | 50.26%-19.81M | ---- | 32.35%-12.26M | ---- |
| Administrative expenses | 4.57%-91.83M | ---- | -12.97%-185.91M | ---- | -35.99%-96.23M | ---- | 4.96%-164.56M | ---- | 31.19%-70.76M | ---- |
| Impairment and provision | 1,155.22%707K | ---- | -136.60%-209K | ---- | -130.32%-67K | ---- | 7,037.50%571K | ---- | 246.36%221K | ---- |
| -Other impairment is provision | 1,155.22%707K | ---- | -136.60%-209K | ---- | -130.32%-67K | ---- | 7,037.50%571K | ---- | 246.36%221K | ---- |
| Special items of operating profit | 34.74%41.64M | ---- | 166.27%76.54M | ---- | 313.74%30.9M | ---- | -25.46%28.75M | ---- | -155.31%-14.46M | ---- |
| Operating profit | 3,950.75%61.84M | 315.33%78.9M | 84.68%-1.61M | -88.78%19M | -109.20%-10.48M | |||||
| Financing cost | -15,976.47%-8.2M | ---- | -1,651.46%-11.4M | ---- | 91.39%-51K | ---- | 60.45%-651K | ---- | 25.35%-592K | ---- |
| Earning before tax | 3,337.42%53.64M | 267.92%67.5M | 85.04%-1.66M | -89.06%18.35M | -109.79%-11.08M | |||||
| Tax | -130.17%-2.6M | ---- | 71.05%-1.52M | ---- | 135.95%8.63M | ---- | -498.86%-5.26M | ---- | -82.44%3.66M | ---- |
| After-tax profit from continuing operations | 631.86%51.04M | 404.20%65.98M | 194.01%6.97M | -92.26%13.09M | -105.54%-7.42M | |||||
| Earning after tax | 631.86%51.04M | 404.20%65.98M | 194.01%6.97M | -92.26%13.09M | -105.54%-7.42M | |||||
| Profit attributable to shareholders | 631.86%51.04M | 404.20%65.98M | 194.01%6.97M | -92.26%13.09M | -105.54%-7.42M | |||||
| Basic earnings per share | 636.36%0.0243 | 408.06%0.0315 | 194.29%0.0033 | -92.31%0.0062 | -105.43%-0.0035 | |||||
| Diluted earnings per share | 636.36%0.0243 | 408.06%0.0315 | 194.29%0.0033 | -92.31%0.0062 | -105.43%-0.0035 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.